Detection of HER 2 Status in Breast Cancer : Comparison of

@inproceedings{Pazhoomand2014DetectionOH,
  title={Detection of HER 2 Status in Breast Cancer : Comparison of},
  author={Reza Pazhoomand and Elahe Keyhani and Hossein Najmabadi and Faranak Khodadadi and Alireza Iraniparast and Farnaz Feiz and Ideh Bahman and Atoosa and Seyedeh Sedigheh Abedini and Farkhondeh Behjati},
  year={2014}
}
Breast cancer is responsible for 28% of the newly diagnosed cancer cases in women worldwide (Siegel et al., 2013). Iranian female breast cancer patients are affected at least 10 years earlier (average age of diagnosis, 47.1-48.8 years old) than those in Western countries (Babu et al., 2011). The treatment regimens for breast cancer patients are selected according to the biology and behavior of the tumor and depends on several factors such as: the human epidermal growth factor receptor 2 (HER2… CONTINUE READING
2 Citations
33 References
Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Comparison of HER2 expression by immunohistochemistry (IHC) hybridization (FISH). A retrospective analysis of 2853 cases

  • R Collins, D Xiang, A Christie
  • Cancer Res,
  • 2012
2 Excerpts

Trastuzumab cancer patients

  • L Del Mastro, M Lambertini, C Bighin
  • Expert Rev Anticancer Ther,
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…